SELECTBIO - Track One Keynote Speakers

Home

Agenda

Keynote Speakers

Register

Exhibition

Venue

Training Courses

Poster Awards

Agenda Overview

SIMTech Tour

Ai Qun Liu

Professor, Nanyang Technological University

Dr Ai-Qun Liu (A. Q. Liu) received his PhD degree from National University of Singapore (NUS) in 1994. Currently, he is a Professor at School of Electrical & Electronic Engineering, Nanyang Technological University (NTU). He serves as an editor and editorial board member of several journals. He is the author or co-author of over 150 publications including peer-reviewed journal papers and two books. Also, he is OSA Fellow, RCS Fellow and SPIE Fellow.

Christopher Lowe

Professor, University of Cambridge, Director, Cambridge Academy of Therapeutic Sciences

Professor Christopher R. Lowe was founder Director of the Institute of Biotechnology at the University of Cambridge and conducts research in both diagnostics and therapeutics in the healthcare biotechnology sector. He is a fellow of the Royal Academy of Engineering, the Institute of Physics and the Royal Society of Chemistry. He has 395 peer-reviewed publications, 8 books and monographs, >100 patents and has supervised >95 PhD students and has a number of national and international prizes: “Queen’s Award for Technological Achievement”; “Queen’s Anniversary Prize for Higher and Further Education”; “Most Entrepreneurial Scientist of the UK”; OBE in the Queen’s New Year Honours; BBSRC Commercial Innovator of the Year in 2011. He has been the driving force for the establishment of 11 spin-out companies including ProMetic Biosciences Inc (Market Cap $1.9-2.1B), Cambridge Sensors Ltd, Paramata Ltd, Psynova Neurotech Ltd and Royale Therapeutics Ltd., has a number of directorships and fosters entrepreneurship within the University via a Master’s in Bioscience Enterprise, the University’s Seed Fund Committee and other Business School and student-led activities. He is active in various government committees and in a number of legal and entrepreneurial roles. His group's primary research interest is in healthcare biotechnology, particularly where it is applied to the biopharmaceutical, sensors and diagnostics and enzyme and microbial technology sectors. The work is highly multidisciplinary and not only covers aspects of molecular biology, biochemistry, microbiology, chemistry, physics, electronics and engineering, but also the entire range from fundamental science to strategic and applied science. He is currently Director of the newly established Cambridge Academy of Therapeutic Sciences (CATS) within the University of Cambridge.

Christopher Lowe

Professor, University of Cambridge, Director, Cambridge Academy of Therapeutic Sciences

Zhiping Wang

Director, Singapore Institute Of Manufacturing Technology A''STAR

Dr. Wang Zhiping is the Director of Research Programme of Singapore Institute of Manufacturing Technology (SIMTech), where he is leading several multidiscipline research programmes in developing emerging technologies for industrial applications, including microfluidics manufacturing, large area processing and biomanufacturing. Dr. Wang received his D.Phil degree in Engineering Science in 1990 from Oxford University. Since then, he had held various positions as Research Fellow, Senior Research Fellow, Group Manager of Singapore Institute of Manufacturing Technology (1992-2002), Senior Manager of Global Industry Technology Center, Philips Mobile Display Systems (2002-2006), CTO of Advanpack Solutions (2006-2007), and Programme Manager of Microfluidics Manufacturing Programme in SIMTech (2007-2014). His current research interest is in microfluidics technology and its applications.

David Weitz

Professor, Harvard University

David A. Weitz is the Mallinckrodt Professor of Physics and Applied Physics at Harvard University, where he has an appointment in both the Physics Department and the School of Engineering and Applied Sciences. He received his B.Sc. in Physics from the University of Waterloo, and his PhD in Physics from Harvard. His research efforts include soft matter physics, biophysics and biotechnology. He is co-Director of Harvard's NSF-funded Materials Research Science and Engineering Center and of the BASF Advanced Research Initiative.

Jackie Ying

Executive Director, Institute of Bioengineering and Nanotechnology

Jackie Y. Ying received her B.E. and Ph.D. from The Cooper Union and Princeton University, respectively. She joined the faculty at Massachusetts Institute of Technology in 1992, where she was Professor of Chemical Engineering until 2005. She has been the Founding Executive Director of the Institute of Bioengineering and Nanotechnology in Singapore since 2003. For her research on nanostructured materials, Prof. Ying has been recognized with the American Ceramic Society Ross C. Purdy Award, David and Lucile Packard Fellowship, Office of Naval Research Young Investigator Award, National Science Foundation Young Investigator Award, Camille Dreyfus Teacher-Scholar Award, American Chemical Society Faculty Fellowship Award in Solid-State Chemistry, Technology Review’s Inaugural TR100 Young Innovator Award, American Institute of Chemical Engineers (AIChE) Allan P. Colburn Award, Singapore National Institute of Chemistry-BASF Award in Materials Chemistry, Wall Street Journal Asia’s Asian Innovation Silver Award, International Union of Biochemistry and Molecular Biology Jubilee Medal, Materials Research Society Fellowship, Royal Society of Chemistry Fellowship, and American Institute for Medical and Biological Engineering Fellowship.

Prof. Ying was elected a World Economic Forum Young Global Leader, and a member of the German National Academy of Sciences, Leopoldina. She was named one of the “One Hundred Engineers of the Modern Era” by AIChE in its Centennial Celebration. She was selected by The Muslim 500 in 2012, 2013 and 2014 to be one of the world’s 500 most influential muslims. She was selected as an Inaugural Inductee for the Singapore Women’s Hall of Fame in 2014. She is the Editor-in-Chief of Nano Today, which has an impact factor of 18.432.

Johnson Zhang

Vice President And General Manager, PerkinElmer Asia Pacific

Johnson Zhang, ??,Vice President and General Manager of PerkinElmer Diagnostics BU for APAC. He joined PerkinElmer in 2009 with the acquisition of Symbio, he was the Chairman and CEO of Symbio, which he founded in 2000. Symbio is a famous Chinese IVD manufacturer, one of the biggest infectious disease IVD reagent and instrument suppliers in China. From end of 2009, Johnson was leading PerkinElmer Diagnostics business in APAC, focus on Infectious Disease, Neoborn Screening and Maternal Fetal Health areas. He is experienced in R&D, production, Selling Marketing and business development management for IVD products, especially immunochemistry and molecular platforms.